News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Align Technology, Inc. (ALGN) Provides Update Regarding Patent Case Against ClearCorrect


7/26/2013 11:54:49 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN JOSE, CA--(Marketwired - July 26, 2013) -

Align Technology, Inc. (NASDAQ: ALGN) today provided an update regarding the International Trade Commission (ITC) release issued on July 25, 2013 stating that it has decided to review the Administrative Law Judge (ALJ) Rogers' final Initial Determination (ID), which was issued back on May 6, 2013.

Commenting on the ITC release yesterday, Roger E. George, Align Technology vice president corporate and legal affairs and general counsel said, "The ITC yesterday announced that it will review the Administrative Law Judge's finding that ClearCorrect violated Section 337 by infringing Align's valid patents. In recent years, the ITC has reviewed almost every Initial Determination finding a violation of Section 337 in a contested matter, so the decision by the Commission to review the judge's determination that ClearCorrect infringes 37 valid claims from 6 different Align patents is neither unexpected nor remarkable. The Commission's final determination will be made by late September 2013. Align fully expects the Commission to adopt the findings of validity and infringement by ClearCorrect contained in the Administrative Law Judge's 816-page ruling and impose the remedies recommended by the judge, including a cease and desist order preventing ClearCorrect from importing its infringing digital treatment plans and other digital data from the former OrthoClear employees who now work for ClearCorrect in Pakistan."

About Align Technology, Inc.
Align Technology designs, manufactures and markets Invisalign, a proprietary method for treating malocclusion, or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, Invisalign significantly reduces the aesthetic and other limitations associated with braces. Invisalign is appropriate for treating adults and teens. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998.The Invisalign product family includes Invisalign, Invisalign Teen, Invisalign Assist, Invisalign Express 10, Invisalign Express 5, Invisalign Lite, and Vivera Retainers. To learn more about Invisalign or to find an Invisalign trained doctor in your area, please visit www.invisalign.com.

Cadent Holdings, Inc. is a subsidiary of Align Technology and is a leading provider of 3D digital scanning solutions for orthodontics and dentistry. The Cadent family of products includes the iTero scanning systems, OrthoCAD iCast and OrthoCAD iRecord. For additional information, please visit www.cadentinc.com.




Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES